UMediC Group Berhad (KLSE:UMC)

Malaysia · Delayed Price · Currency is MYR

0.2950

-0.0100 (-3.28%)

At close: Sep 2, 2026

-26.25% (1Y)

Market Cap	110.30M -26.3%
Revenue (ttm)	52.29M +2.2%
Net Income	8.18M -5.8%
EPS	0.02 -5.9%
Shares Out	373.91M
PE Ratio	13.50
Forward PE	14.05
Dividend	0.01 (1.97%)
Ex-Dividend Date	Jan 29, 2026

Volume	173,000
Open	0.3000
Previous Close	0.3050
Day's Range	0.2950 - 0.3000
52-Week Range	0.2800 - 0.4750
Beta	0.19
Analysts	Buy
Price Target	0.35 (+18.64%)
Earnings Date	Sep 11, 2026

About UMediC Group Berhad

UMediC Group Berhad, an investment holding company, develops, manufactures, markets, and distributes medical devices and consumables in Malaysia, the Asia Pacific, the Americas, Europe, the Middle East, Africa, and Oceania. The company operates nursing homes and healthcare centers, and other related services; markets and distributes laboratory equipment and consumables; and provides after-sales services. It also provides HYDROX prefilled humidifiers and nebulizers; AIRDROX inhaler spacers; FLEXIDROX water for inhalation bag; and hospital furnit... [Read more]

Industry Medical, Dental, and Hospital Equipment and Supplies

Founded 2021

Employees 166

Stock Exchange Bursa Malaysia

Ticker Symbol UMC

Full Company Profile

Financial Performance

In fiscal year 2025, UMediC Group Berhad's revenue was 48.56 million, a decrease of -11.01% compared to the previous year's 54.57 million. Earnings were 8.13 million, a decrease of -9.53%.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for UMC stock is "Buy." The 12-month stock price target is RM 0.35, which is an increase of 18.64% from the latest price.

Price Target

RM 0.35

(18.64% upside)

Analyst Consensus: Buy

Stock Forecasts